Applitech is a biopharmaceutical technology company specializing in production of bioreactors, analytical equipment, single-use devices, and integrated bioprocess solutions. Guided by the principle of "Quality First, Service Foremost," Applitech is customer-focused and committed to supporting bioprocess optimization, scale-up, and manufacturing with professional, end-to-end solutions.
With nearly two decades of expertise in bioreactor technology, Applitech develops high-quality, self-branded bioreactors covering R&D, pilot, and cGMP production. Their solutions support antibody, vaccine, cell therapy, gene therapy, and stem cell therapy research and manufacturing. Centered on bioreactor platforms, Applitech offers a comprehensive product ecosystem including process monitoring, spectroscopic analysis, cell analysis, online sampling, and sample treatment, helping biopharmaceutical partners achieve continuous innovation and breakthroughs.